American Century Companies’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-328,920
Closed -$5.21M 2918
2024
Q4
$5.21M Buy
328,920
+31,251
+10% +$495K ﹤0.01% 1586
2024
Q3
$17.3M Sell
297,669
-501
-0.2% -$29.1K 0.01% 1087
2024
Q2
$13.6M Buy
298,170
+59,364
+25% +$2.71M 0.01% 1116
2024
Q1
$15.8M Buy
238,806
+24,209
+11% +$1.6M 0.01% 1019
2023
Q4
$8.53M Buy
214,597
+523
+0.2% +$20.8K 0.01% 1211
2023
Q3
$6.82M Buy
214,074
+71
+0% +$2.26K 0.01% 1218
2023
Q2
$8.6M Buy
214,003
+100,860
+89% +$4.05M 0.01% 1122
2023
Q1
$4.82M Buy
+113,143
New +$4.82M ﹤0.01% 1275